Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000864479 | SCV001471840 | likely benign | not provided | 2020-03-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001276073 | SCV001612331 | likely benign | Tay-Sachs disease | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001276073 | SCV001786789 | likely benign | Tay-Sachs disease | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003908200 | SCV004723728 | likely benign | HEXA-related disorder | 2021-10-29 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001276073 | SCV001461910 | uncertain significance | Tay-Sachs disease | 2018-07-20 | no assertion criteria provided | clinical testing |